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Repeatability of intraocular pressure
measurements with Icare PRO rebound, Tono-Pen
AVIA, and Goldmann tonometers in sitting and
reclining positions
Caterina Schweier1, James VM Hanson1, Jens Funk1 and Marc Töteberg-Harms1,2*
Abstract
Background: Icare PRO (ICP) is a new Rebound tonometer that is able to measure intraocular pressure (IOP) in
both sitting and reclining positions. In this study, the gold standard Goldmann tonometer (GAT) was compared to
ICP and Tono-Pen AVIA (TPA). Hypothesis was that repeatability of GAT is superior to ICP and TPA.
Methods: 36 eyes of 36 healthy caucasian individuals, 13 male and 26 females, 17 right and 19 left eyes have
been included in this prospective, randomized, cross-sectional study. The study was conducted at a single site
(Dept. of Ophthalmology, UniversityHospital Zurich, Switzerland). Primary outcome measures were Intraclass
correlation coefficients (ICC) and coefficients of variation (COV) and test-retest repeatability as visualized by
Bland-Altman analysis. Secondary outcome measures were IOP in sitting (GAT, ICP and TPA) and in reclining
(ICP and TPA) position.
Results: Mean IOP measured by GAT was 14.9±3.5 mmHg. Mean IOP measured by ICP was 15.6±3.1 mmHg (with
TPA 14.8±2.7 mmHg) in sitting and 16.5±3.5 mmHg (with TPA 17.0±3.0 mmHg) in reclining positions. COVs ranged
from 2.9% (GAT) to 6.9% (ICP reclining) and ICCs from 0.819 (ICP reclining) to 0.972 (GAT).
Conclusions: Repeatability is good with all three devices. GAT has higher repeatability compared to the two
tested hand-held devices with lowest COVs and highest ICCs. IOP was higher in the reclining compared to the
sitting position.
Trial registration: The study was registered to the Clinical Trials Register of the US National Institute of Health,
NCT01325324.
Background
A precise measure of intraocular pressure (IOP) is es-
sential in diagnosing and managing many ophthalmo-
logical diseases, particularly in glaucoma.
The gold standard in measuring IOP remains Goldmann
applanation tonometry (GAT; Haag-Streit AG, Könitz,
Switzerland) which was first introduced in 1957 by Hans
Goldmann [1]. However, it is well known that corneal
biomechanical properties influence the measured IOP
value. For example, there is evidence that central corneal
thickness (CCT) affects IOP readings by GAT in that IOP
is underestimated in thin and overestimated in thick cor-
neas [2-4]. Corneal edema [5], corneal astigmatism [6], re-
fractive corneal surgery [7] and corneal hysteresis [8] also
affect IOP readings.
For IOP measurement with GAT the patient must be
able to sit at a slit lamp with a slit lamp-mounted GAT
in an upright position. In some cases this is impossible,
e.g. bed-ridden persons, small children, intraoperative
assessments, and in other situations outside of the con-
sulting room. In these cases hand-held tonometers are
used. Many hand-held devices are available to measure
IOP when the patient is either sitting upright or recli-
ning horizontally. All have advantages and disadvantages
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compared to GAT. The Tono-Pen AVIA (TPA; Reichert
Inc., Depew, New York, USA) is currently widely used.
A more recently available option is the Icare PRO Re-
bound Tonometer (ICP; Icare Finland Oy, Helsinki,
Finland). A previous version of the ICP was only able to
measure IOP in the sitting position but with the pro
version the clinician can measure IOP in both sitting
and reclining positions.
TPA uses the same physical principle as GAT to meas-
ure IOP but the applanated area is much smaller (ap-
proximately 1.0mm in diameter) [9-12]. Ten consecutive
readings are averaged and the result is provided along
with a statistical confidence indicator.
ICP uses an impact rebound technique [13]. A small
probe is accelerated against the cornea and the re-
bound acceleration is measured and translated into IOP
[14-16]. The contact with the corneal surface is very
brief and therefore no local anaesthesia is needed. This
is an advantage in examination of children. Another ad-
vantage is that the rebound technique does not require
continuous calibration. ICP averages six consecutive IOP
measurements and provides the mean IOP out of these
six measurements. ICP indicates the reliability of the
measurements by a color code displayed below the IOP
result. If the variation is within normal limits the indica-
tor is green, yellow when the variation is greater than
normal and the measurements should be viewed with
caution and red when the variation is unacceptably high.
Whenever a device other than the gold standard is to
be used, it should be one that offers increased precision
relative to the gold standard. The aims of this study were
to check if the repeatability of the ICP and TPA are
comparable to GAT, if the IOP reading is equal in all
three devices, and if there are any differences between
IOP measured by GAT and by the two tested hand-held
devices in sitting and reclining positions.
Methods
36 eyes of 36 healthy volunteers (13 male and 26 fe-
males, 17 right and 19 left eyes) with a mean age of
41.9±13.8 years were included into this prospective,
randomized, cross-sectional study. The study was per-
formed at a single site, UniversityHospital Zurich,
Switzerland, between November and December 2011.
The study was pre-approved by the local Ethics commit-
tee (Cantonal Ethics Committee Zurich, Department of
Health Canton Zurich, Zurich, Switzerland) and was
conducted adhering to the tenets of the Helsinki Decla-
ration and in compliance with all local and national
regulations and directives. The study was registered to
the Clinical Trials Register of the US National Institute
of Health http://www.clinicaltrials.gov NCT01325324.
Signed informed consent was obtained prior to the first
examination.
Inclusion criteria were healthy ophthalmological status
and age equal to or greater than 18 years. Exclusion cri-
teria were a history of glaucoma or other ocular disease,
and the presence of any corneal opacity or scarring that
could affect IOP measurement. Only one eye of each in-
dividual was included. A randomization plan for choos-
ing the eye to be enrolled in the study (right or left), and
to determine the order in which the three tested tonom-
eters were employed, and to minimize bias was gener-
ated by using http://www.randomization.com. Sample
size calculations were done using a online tool of the
Biostatistics Center of Massachusetts General Hospital,
Harvard Medical School, Boston, Massachusetts, USA
(http://hedwig.mgh.harvard.edu/sample_size/size.html).
A total of 36 patients have entered this study. With a
probability of 80 percent this study will detect a treat-
ment difference at a two-sided 0.05 significance level, if
the true difference between treatments is 2.4 mmHg
based on standard deviation of 3.5 (or 1.8 mmHg based
on a standard deviation of 2.7). IOP was measured first
in an upright position with ICP, TPA and GAT (twice
per device). Then, the patient reclined horizontally for
10 minutes and IOP was again measured twice with each
of the hand-held devices (ICP and TPA). Between re-
peated measurement there was a pause of 3 minutes to
avoid a lower IOP of the subsequent measurement
caused by the prior applanation. If the statistical confi-
dence indicator of the TPA was below 95% the measure-
ment was repeated. ICP measurement was repeated until
the quality indicator showed good repeatability (green).
To minimize the influence of diurnal IOP fluctuation, all
measurements were taken between 3 pm and 6 pm. Statis-
tical analysis was performed using Excel for Windows
(Microsoft Office 2003, Microsoft Corp., WA, USA) and
SPSS/PASW statistics software (Version 18.0.0 for Macin-
tosh, SPSS Inc. Chicago, IL, USA). The measurements
were not normally distributed, as shown by Kolmogorov-
Smirnov and Shapiro-Wilks tests. There was no post-hoc
test with non-parametric Kuskall-Wallis-testing. Therefore,
a logarithmic variable stabilizing transformation was
performed to make use of one-way ANOVA. STATA™
(Version 10.1, StataCorp, Texas, USA) was used for the
computation of the linear mixed models and Bland-
Altman plots were created using MedCalc™ (MedCalc Soft-
ware 7.3.0.1, Mariakerke, Belgium). Following the statistical
analysis, differences between IOP values were considered
statistically significant when p-values were less than 0.05.
For statistical analysis, mean IOP for each experimen-
tal condition for each of the three tonometers was calcu-
lated from two measurements. Coefficients of variation
(COV) were determined for each tonometer and for sit-
ting and reclining positions separately. Intraclass cor-
relation coefficients (ICC) were determined with the
procedure ‘xtmixed’ in STATA to evaluate differences in
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IOP between each of the three tonometers [17]. The lin-
ear mixed effects model was also used to evaluate differ-
ences in IOP measurement between sitting and reclining
positions within ICP and TPA, respectively. In addition
95%-limits of agreement for consistency and the bias
between the tonometers were evaluated by means of
Bland-Altman analysis [18,19]. Limits of agreement are
defined as the mean of the differences plus/minus 1.96
standard deviations (SD) of the differences. They provide
an interval within which 95% of the differences between
measurements by the two devices are expected to lie.
The 95% confidence interval (95% CI) for the differences
gives the additional information about the deterministic
bias between both devices. If zero does not fall within
the 95% CI we have to conclude that one of the methods
measures deterministically higher values than the other.
Results
Mean IOP measured by GAT (sitting) was 14.9±3.5
mmHg. Mean IOP measured by TPA was 14.8±2.7 mmHg
whilst sitting upright and 17.0±3.0 mmHg in the reclining
position. Mean IOP measured by ICP was 15.6±3.1 mmHg
whilst sitting upright and 16.5±3.5 mmHg in the reclining
position.
Coefficients of variation (COV) ranged from 2.9% for
GAT to 6.9% for ICP in the reclining position. The COV
can be found in Table 1. COV was best for GAT (2.9%).
A statistically significant difference in COV was only
found between ICP whilst reclining and GAT whilst sit-
ting upright (p = 0.026).
The results obtained from the linear mixed model for
the ICCs are provided in Table 2. ICCs ranged from
0.819 for ICP whilst reclining to 0.972 for GAT whilst
sitting upright. The model was used to evaluate diffe-
rences in IOP (ΔIOP) between GAT and all other devices
(Table 2). IOP was higher measured by ICP and TPA com-
pared to GAT with ΔIOP=0.847 mmHg for ICP in upright
(p = 0.007) and ΔIOP=1.651 mmHg for ICP in reclining
positions (p < 0.001), and ΔIOP=0.528 mmHg for TPA in
sitting (p = 0.095) and ΔIOP=2.306 mmHg for TPA in re-
clining position (p < 0.001). With ICP, ΔIOP in the reclin-
ing compared to the upright position was −0.804 mmHg
(SD = 0.297, 95%-CI −1.387, -0.221, p = 0.007). With
TPA, ΔIOP in the reclining compared to the upright pos-
ition was −1.778 mmHg (SD = 0.266, 95%-CI −2.300,
-1.256, p < 0.001). In the reclining position ΔIOP between
ICP compared to TPA was 0.654 mmHg (SD = 0.300,
95%-CI 0.066, 1.242, p = 0.029) whereas no significant dif-
ference could be found between both devices in the sitting
upright position, with ΔIOP between ICP and TPA
being −0.319 (SD = 0.295, 95%-CI −0.898, 0.259, p = 0.279).
Bland-Altman plots were used to demonstrate dif-
ferences between measurement 1 and 2 of the three
methods in sitting position (Figure 1). Furthermore,
Bland-Altman plots were used to show differences be-
tween both hand-held tonometers in both positions (sit-
ting and reclining) compared to GAT (Figure 2) and
between sitting and reclining positions within both
hand-held tonometers (Figure 3). Bias and limits of
agreement as well as confidence intervals and p-values
Table 1 Coefficients of variation (COV)
COV Mean SD 95%-CI Median Min Max p-value
Lower Upper
GAT (S) 0.029 0.034 0.018 0.041 0.000 0.000 0.109 -
ICP (S) 0.052 0.052 0.035 0.070 0.036 0.000 0.229 0.430
ICP (R) 0.069 0.059 0.049 0.089 0.050 0.000 0.224 0.026
TPA (S) 0.052 0.054 0.034 0.070 0.049 0.000 0.223 0.426
TPA (R) 0.042 0.048 0.035 0.070 0.036 0.000 0.229 0.878
(GAT Goldmann-Applanation-Tonometer, ICP Icare PRO, TPA Tono-Pen AVIA, SD Standard deviation, CI confidence interval, S sitting, R reclining).
Table 2 Results from the linear mixed model (ICC and ΔIOP)
ICC SD 95%-CI ΔIOP SD 95%-CI p-value
Lower Upper Lower Upper
GAT (S) 0.972 0.009 0.949 0.986 - - - - -
ICP (S) 0.866 0.042 0.767 0.931 0.847 0.316 0.228 1.466 0.007
ICP (R) 0.819 0.055 0.693 0.907 1.651 0.316 1.032 1.270 <0.001
TPA (S) 0.876 0.022 0.784 0.937 0.528 0.316 −0.091 1.147 0.095
TPA (R) 0.931 0.039 0.877 0.965 2.306 0.316 1.687 2.925 <0.001
(GAT Goldmann-Applanation-Tonometer, ICP Icare PRO, TPA Tono-Pen AVIA, SD Standard deviation, CI confidence interval, ΔIOP difference op IOP compared to
GAT in mmHg, S sitting, R reclining).
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are provided in Table 3. Bland Altman plots show good
repeatability between IOP reading 1 and 2 (Figure 1).
Bias was very low for all devices and ranges between
0.0 mmHg for TPA in reclining and 0.1 mmHg for TPA
in upright positions. IOP was higher measured by ICP
and TPA compared to GAT by 0.8 mmHg for ICP in
Figure 1 Bland-Altman plots to demonstrate repeatability in measuring IOP (mmHg) between reading 1 and 2 with all devices (GAT a,
ICP b and c and TPA d and e) and positions (sitting b and d and reclining c and e). Limits of agreement were provided as 1.96-times
standard deviation with upper and lower limit of the differences. Units for both axes are mmHg. (GAT = Goldmann-Applanation-Tonometer,
ICP = Icare PRO, TPA = Tono-Pen AVIA, SD = Standard deviation, S = sitting, R = reclining).
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sitting and 1.7 mmHg for ICP in reclining position, and
by 0.5 mmHg for TPA in sitting and 2.3 mmHg for TPA
in reclining positions (Figure 2). IOP was higher in the
reclining compared with upright position (Figure 3).
The effect was greater for TPA (1.8 mmHg) than for
ICP (0.8 mmHg).
Discussion
The accurate measurement of intraocular pressure is im-
portant in managing many ophthalmic diseases and con-
ditions, e.g. glaucoma, uveitis, and traumatic conditions
such as hyphema. The most accurate method of measur-
ing intraocular pressure remains cannulation of anterior
chamber and direct manometry. Because of its invasive
nature and the risk of adverse effects, e.g. infection, this
method is reserved for some experimental designs only.
Hence, the gold standard of clinical IOP measurement
remains Goldmann applanation tonometry. GAT can
routinely be performed in the consultation room with a
slit lamp-mounted device. However, GAT can only be
performed whilst the patient is sitting upright at the slit
lamp. In some instances, for example post-trauma exam-
ination in the emergency room or an intensive care unit,
it is impossible to use the slit lamp-mounted GAT. In
these conditions a hand-held device is used to measure
IOP. Sometimes it is only possible to examine the pa-
tient whilst they are reclining horizontally. Whenever
the use of a tonometer other than the gold standard
GAT is considered, the operator should know if IOP
measurements with the hand-held devices are reliable
and by how much the IOP in these settings differs from
IOP measurement with GAT in the upright position.
The aim of this study was to evaluate these two ques-
tions. Firstly, the repeatability of all devices was tested.
Therefore, COVs and ICCs were calculated. COVs and
ICCs were good for all three devices and both positions
Figure 2 Bland-Altman plots to demonstrate differences in mean IOP (mmHg) between Goldmann-Applanation-Tonometer and the
two hand-held devices separately for both positions (sitting and reclining), Icare PRO (a, b) and Tono-Pen AVIA (c, d). Limits of
agreement were provided as 1.96-times standard deviation with upper and lower limit of the differences. Units for both axes are mmHg.
(GAT = Goldmann-Applanation-Tonometer, ICP = Icare PRO, TPA = Tono-Pen AVIA, SD = Standard deviation, M = mean, S = sitting, R = reclining).
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(sitting upright as well as reclining). Nevertheless, GAT
showed the lowest COV and highest ICC. A significant
difference for COVs could only be detected between
GAT in sitting and ICP in reclining positions. ICC was
best (highest) for GAT and worst (lowest) for ICP in the
reclining position. In the latter case there was even no
overlapping of the 95% confidence intervals. Bland-
Altman analysis was used to check the test-retest repeat-
ability of one single operator in the upright and reclining
positions. Bland-Altman analysis shows good repeatabi-
lity with low bias between test (measurement one) and
retest (measurement 2) for all three tested devices and
in both positions. Limits of agreement were best for
GAT compared to the two hand-held devices.
Second, this study evaluated the amount in which the
IOP measured by the hand-held devices in both upright
and reclining positions differs from the IOP measure-
ment with GAT in the upright position. Mean IOP dif-
fers between all tonometers, and between upright and
reclining positions when using ICP or TPA. IOP was
generally lower in the sitting upright compared to the re-
clining position. This is consistent with previous studies
Figure 3 Bland-Altman plots to demonstrate differences in IOP (mmHg) between sitting and reclining positions within the two hand-
held tonometers, Icare PRO (a) and Tono-Pen AVIA (b). Limits of agreement were provided as 1.96-times standard deviation with upper and
lower limit of the differences. Units for both axes are mmHg. (ICP = Icare PRO, TPA = Tono-Pen AVIA, SD = Standard deviation, M = mean,
S = sitting, R = reclining).
Table 3 Summaries of the Bland-Altman plots
Bias Limits of agreement 95%-CI p-value
Lower Upper Lower Upper
GAT2 (S) – GAT1 (S) −0.06 −1.74 1.63 −0.235 0.347 0.701
ICP2 (S) – ICP1 (S) −0.2 −3.3 2.8 −0.312 0.745 0.411
ICP2 (R) – ICP1 (R) −0.2 −4.4 4.1 −0.584 0.890 0.676
TPA2 (S) – TPA1 (S) 0.1 −3.3 3.5 −0.699 0.477 0.703
TPA2 (R) – TPA1 (R) 0.0 −2.7 2.7 −0.465 0.465 1.000
MICP (S) – MGAT (S) 0.8 −4.6 6.2 −0.085 1.780 0.074
MICP (R) – MGAT (S) 1.7 −2.9 6.2 0.864 2.439 <0.001
MTPA (S) – MGAT (S) 0.5 −4.1 5.1 −0.266 1.321 0.1856
MTPA (R) – MGAT (S) 2.3 −3.4 8.0 1.319 3.292 < 0.001
MICP (R) – MICP (S) 0.8 −4.0 5.6 −0.032 1.640 0.059
MTPA (R) – MTPA (S) 1.8 −2.8 6.3 0.995 2.560 <0.001
The agreement between measurement 1 and 2 with each tonometer and between GAT and each hand-held tonometer and position (sitting and reclining) and
between sitting and reclining positions within both hand-held tonometers was investigated. Lower and upper limits of agreement were provided as 1.96-times
standard deviation of the differences (SD). Bias, 95% limits of agreement and 95% confidence interval are provided in mmHg.
(GAT Goldmann-Applanation-Tonometer, ICP Icare PRO, TPA Tono-Pen AVIA, CI confidence interval, M mean, S sitting, R reclining).
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[20-22]. The effect was greater for the TPA than for the
ICP. This has been evaluated in other studies with a previ-
ous model of the used Icare PRO, named Icare. But the
Icare was only able to measure IOP in the upright pos-
ition, and not whilst the patient is reclining. To our know-
ledge there are no prior studies comparing GAT and TPA
with the new Icare PRO.
IOP measurements are dependent on central corneal
thickness (CCT). Limitations of our study are that we do
not correlate the measurements with CCT and only
healthy individuals are included. In healthy individuals
we do not expect an unacceptably large range of CCT.
Furthermore, it is not standard clinical practice to mea-
sure CCT in a healthy patient. Therefore, in a standard
clinical setting the hand-held tonometers will be used
without knowing the CCT of these eyes, which could
lead to an unknown bias. However, there is a lack of
consensus on the influence of corneal thickness and
axial length on IOP measurements. Regarding rebound
tonometry, one study found no correlation between
CCT and IOP [23], while others found a correlation
[24,25]. It is known that accuracy of IOP measurement
is affected in eyes with corneal pathologies, e.g. post
keratoplasty, with corneal scarring, with high or irregular
astigmatism, or in the presence of corneal edema [26-31].
This study did not check repeatability in eyes with corneal
pathologies. Another limitation of this study is that only
eyes with IOP between 9 and 27 mmHg (GAT) were in-
cluded, which reflects normal and slightly elevated IOP. It
is known that IOP measured by Tono-Pen corresponds
well with GAT in the range 9-20 mmHg, but underesti-
mates IOP ≥30 mmHg and overestimates IOP ≤9 mmHg
[32-34]. Further studies should evaluate ICP in a larger
sample size including eyes with elevated IOP and a
matched group of patients with glaucoma.
Conclusion
In a clinical setting all three devices may be used be-
cause of their good repeatability. But regarding repeat-
ability, COV and ICC were superior only for GAT, the
other devices should only be used when it is not possible
to use a slit-lamp mounted GAT. TPA has been widely
used for many years now. ICP is a recently-introduced
alternative to TPA. Because no local anaesthesia is
needed, ICP is a good way to measure IOP especially in
children or in adults who are unable to fully co-operate.
If it is impossible to measure in the upright position one
can use TPA or ICP. IOP measurements between GAT,
TPA and ICP as well as between upright and reclining
positions are not interchangeable. If decisions depend on
the exact value of IOP, there is the desire to use conver-
sion factors to compare IOP readings with GAT. Never-
theless, at the moment none conversion formula exists
that would be accurately applicable.
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